Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis.

Francisco Espejo-PorrasLaura García-ToscanoCarmen Rodríguez-CuetoIrene Santos-GarcíaEva de LagoJavier Fernández-Ruiz

Published in: British journal of pharmacology (2018)

This article is part of a themed section on 8th European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc.

Keyphrases

amyotrophic lateral sclerosis
benign prostatic hyperplasia
cancer therapy
lower urinary tract symptoms
neuropathic pain
spinal cord injury
drug delivery
spinal cord